Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
From Gangster to politician: How Daddy Arun Gawli turned his gangster-life into ‘public service’

2018-07-17 freepressjournal.in
One of the most feared names in Mumbai’s underworld. A name that is like a godfather for some and, for some, just a criminal. For some he is gangster and for some he is a politician. He started as mill working Marathi guy from Byculla, then became a dreaded gangster and then a politician and then a convict. Arun Gawli or Arun Gulab Ahir, aka ‘Daddy’ whose life not only sounds flimsy but his life also inspired a movie.
500093 CPGVY CGVA CROMPGREAV CGVD CPGZF

0
Crompton Greaves shares gain 4% after Macquarie retains outperform, sees 27% upside

2018-07-11 moneycontrol
Crompton Greaves Consumer Electrical share price rallied 4 percent intraday on Wednesday after global brokerage firm Macquarie maintained its outperform rating with a target price at Rs 292 per share, implying a 27 percent potential upside.
500093 CPGVY CGVA CROMPGREAV CGVD CPGZF

14
[Press] A Succinct Overview of Europe Oil Filled Distribution Transformer Market With a Regional Frame of Reference, Capacity Expansion Strategies to Characterise Industry Growth Over 2018-2024

2018-05-31 oilvoice
Over the recent years, Europe oil filled distribution transformer market share has been amplifying at a commendable pace owing to the expansion of cross-border distribution projects and massive investments directed toward modernizing the existing grid networks. The European Investment Bank has recently earmarked USD 5.1 billion for energy sector initiatives. The funds would be utilized to construct, expand, and revamp power generation projects across the nations such as France, Italy, Ireland, and Spain.
500093 GEC GE CPGVY GNE CGVA CROMPGREAV CGVD CPGZF

14
[Press] A succinct overview of Europe oil filled distribution transformer market with a regional frame of reference, capacity expansion strategies to characterize industry growth over 2018-2024

2018-05-27 oilvoice
Over the recent years, Europe oil filled distribution transformer market share has been amplifying at a commendable pace owing to the expansion of cross-border distribution projects and massive investments directed toward modernizing the existing grid networks. The European Investment Bank has recently earmarked USD 5.1 billion for energy sector initiatives. The funds would be utilized to construct, expand, and revamp power generation projects across the nations such as France, Italy, Ireland, and Spain.
500093 GEC GE CPGVY GNE CGVA CROMPGREAV CGVD CPGZF

14
[Press] A succinct overview of Europe oil filled distribution transformer market with a regional frame of reference, capacity expansion strategies to characterize industry growth over 2018-2024

2018-05-27 oilvoice
Over the recent years, Europe oil filled distribution transformer market share has been amplifying at a commendable pace owing to the expansion of cross-border distribution projects and massive investments directed toward modernizing the existing grid networks. The European Investment Bank has recently earmarked USD 5.1 billion for energy sector initiatives. The funds would be utilized to construct, expand, and revamp power generation projects across the nations such as France, Italy, Ireland, and Spain.
500093 GEC GE CPGVY GNE CGVA CROMPGREAV CGVD CPGZF

0
Broker's call: Crompton Greaves (Buy)

2018-04-25 thehindubusinessline
Crompton Greaves Consumer Electricals (CGCEL) likely to report a decent PAT growth by 19.3 per cent y-o-y to ₹100 crore in 4QFY18 while EBITDA margin seen improvement by 60 bps to 13.8 per cent led by improved margin in electrical consumer durable and lighting products business.
500093 CPGVY CGVA CROMPGREAV CGVD CPGZF

21
Essar Group sells Equinox Business Park to Brookfield

2018-04-24 livemint
Mumbai: Essar Group on Tuesday said it has completed the sale of Equinox Business Park, its commercial property in Mumbai’s Bandra-Kurla Complex, to Canada’s Brookfield Asset Management Inc. for Rs2,400 crore.
500093 BAMGF CPGVY CGVA TATACOMM CROMPGREAV 500483 BAMKF BAM CGVD CPGZF

0
Crompton Greaves expands product portfolio

2018-04-24 moneycontrol
Electrical appliances maker Crompton Greaves Consumer Electricals Ltd today unveiled a new range of fans and air-coolers as part of expansion of its product portfolio.
500093 CPGVY CGVA CROMPGREAV CGVD CPGZF

0
CGCEL CEO says aim to be among top 4 players in appliances market; open to acquisitions

2018-04-17 moneycontrol
Consumer durables company Crompton Greaves Consumer Electricals (CGCEL) has launched two new products in the fan and cooler space to meet the surging demand for products that can help beat the agonising heat.
500093 CPGVY CGVA CROMPGREAV CGVD CPGZF

20
19
News Live: Mood in Karnataka favours Congress, says Rahul Gandhi

2018-04-09 moneycontrol
Casualties reported in strike on Syria air base: state media A missile attack on a Syrian military airport left several dead and wounded, state media said today, after the US warned Damascus and its allies over an earlier suspected chemical attack on a rebel-held town.The strike on the Tayfur air base in the central province of Homs, came as international outrage mounts over an attack on Saturday in the rebel enclave of Eastern Ghouta.
BAJAJ-AUTO BHRYY CPGVY 500820 ADANIENT 532617 532977 512599 ASIANPAINT 532215 500093 505200 532483 AXISBANK 534816 HEROMOTOCO CGVA INFRATEL BEL EICHERMOT CGVD BHQRY ECQRY ABB ANNRY AXB JETAIRWAYS CROMPGREAV CPGZF CNRYY AXBKY 500182 AXBA 500002 ABBDY HRTQY 500049 CANBK

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...